Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation
OwnerLudwig Pichler, Eva-Maria Muchitsch +4inventors
InventorsLudwig Pichler, Eva-Maria Muchitsch, Anton Philapitsch, Hans-Peter Schwarz, Yendra Linnau, Wolfgang Teschner
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of human α1-acid glycoprotein (AGP) for producing a pharmaceutical preparation for treating non-inflammatory disturbances of circulation or microcirculation, respectively.
Claims19
The use of human α1-acid glycoprotein for producing a pharmaceutical preparation for treating non-inflammatory disturbances of circulation or microcirculation, respectively.
Infusion preparation for treating shock conditions, comprising α1-acid glycoprotein and a vasoactive substance as its active components.
A kit for treating shock conditions, comprising
- a) α1-acid glycoprotein in a pharmaceutical preparation, and
- b) a vasoactive substance.
Dependencies are inferred from the claim text.